Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007357. doi: 10.1002/14651858.CD007357.pub2

Comparison 1.

Etodolac 50 mg versus placebo

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Participants with at least 50% pain relief over 4 to 6 hours 4 360 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [1.14, 2.56]
2 Participants with at least one adverse event 4 320 Risk Ratio (M-H, Fixed, 95% CI) 1.44 [0.64, 3.19]